Nearly 50% of Phase III clinical trials carried out by the National Cancer Institute (NCI)-sponsored SWOG Cancer Research Network, one of five groups in NCI’s National Clinical Trials Network (NCTN), was associated with clinical care guidelines or new drug approvals....